Trump Should Stand Firm Against Europe’s Drug Price Free-Riders

For decades, wealthy foreign governments have left it to Americans to pay for pharmaceutical innovation — and then insisted on enjoying the fruits of that innovation at a discount.

President Trump has begun challenging that status quo through trade negotiations designed to pressure foreign countries into paying more for innovative medicines. Unsurprisingly, many of them are furious.

That’s a sign that the strategy is working.

Read the entire op-ed here.